Actively hiring
Molecular Diagnostics
Precision Medicine
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Latest round
Pre-Seed
Jan 2026 · 8 mo ago
Team
11-50
employees, estimated range
The money's age
Fresh money
8 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Tractionpublic signals, read monthly
Web presence
top 10%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Pre-Seed | Jan 2026 | — | GF BRYCK Ventures lead | gruenderfonds-ruhr.com |
Similar startupsby what they do, their industry and backers

Expanding PCR testing to a whole new range of conditions. Making precision diagnostics accessible around the planet. Our technology…

Founded in 2021 by four Seoul National University medical researchers, Portrai fuses spatial biology and AI to make drug development…

RareCyte, Inc. is a Seattle-based precision biology company developing advanced platforms and services for spatial biology and liquid…

RNA intelligence for precision oncology. Blank Bio builds AI foundation models that help pharma teams identify the right patients for…

Eupnoos develops digital biomarkers of cardiopulmonary change. Vita captures. SounDx-FM analyses. INFER supports interpretation.

Cellply offers an automated platform for functional precision medicine.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Garching bei München
Germany
HQ
10-50 est. staff
Financials
Latest round
Pre-Seed
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Pre-Seed | 2026 | — | Details |
